Zhan Yun, Li Xukun, Liang Xiaoshuan, Li Lin, Cao Bangrong, Wang Baona, Ma Jianlin, Ding Fang, Wang Xiang, Pang Da, Liu Zhihua
State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
State Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Oncotarget. 2017 Jan 17;8(3):4629-4641. doi: 10.18632/oncotarget.13542.
Metastasis is a multi-step process. Tumor cells occur epithelial-mesenchymal transition (EMT) to start metastasis, then, they need to undergo a reverse progression of EMT, mesenchymal-epithelial transition (MET), to colonize and form macrometastases at distant organs to complete the whole process of metastasis. Although microRNAs (miRNAs) functions in EMT process are well established, their influence on colonization and macrometastases formation remains unclear. Here, we established an EMT model in MCF-10A cells with SNAI1 overexpression, and characterized some EMT-related microRNAs. We identified that miR-182, which was directly suppressed by SNAI1, could enable an epithelial-like state in breast cancer cells in vitro, and enhance colonization and macrometastases in vivo. Subsequent studies showed that miR-182 exerted its function through targeting its suppressor SNAI1. Moreover, higher expression level of miR-182 was detected in metastatic lymph nodes, compared with paired primary tumor tissues. In addition, the expression level of miR-182 was negatively correlated with that of SNAI1 in these clinical specimens. Taking together, our findings describe the role of miR-182 in colonization and macrometastases in breast cancer for the first time, and provide a promise for diagnosis or therapy of breast cancer metastasis.
转移是一个多步骤过程。肿瘤细胞发生上皮-间质转化(EMT)以启动转移,然后,它们需要经历EMT的逆向进程,即间质-上皮转化(MET),以便在远处器官定植并形成大转移灶,从而完成整个转移过程。尽管微小RNA(miRNA)在EMT过程中的功能已得到充分证实,但其对定植和大转移灶形成的影响仍不清楚。在此,我们在过表达SNAI1的MCF-10A细胞中建立了一个EMT模型,并对一些与EMT相关的微小RNA进行了表征。我们发现,受SNAI1直接抑制的miR-182能够在体外使乳腺癌细胞呈现上皮样状态,并在体内增强定植和大转移灶形成。后续研究表明,miR-182通过靶向其抑制因子SNAI1发挥作用。此外,与配对的原发性肿瘤组织相比,在转移性淋巴结中检测到更高水平的miR-182。另外,在这些临床标本中,miR-182的表达水平与SNAI1的表达水平呈负相关。综上所述,我们的研究首次描述了miR-182在乳腺癌定植和大转移灶形成中的作用,并为乳腺癌转移的诊断或治疗提供了希望。